Expand CRSP Menu
CRSP MENU

CRSP Latest Press Releases

-- December 16, 2025 --

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes Globe Newswire 12:00 PM

-- December 9, 2025 --

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PRNewswire 11:58 AM

-- November 19, 2025 --

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care Globe Newswire 10:06 AM

-- November 10, 2025 --

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results Globe Newswire 8:00 AM

-- November 8, 2025 --

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310 Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering Globe Newswire 9:56 AM

-- October 10, 2025 --

CRISPR Therapeutics Presents New Preclinical Data for CTX460 Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Editing Platform Globe Newswire 8:00 AM

-- October 2, 2025 --

Australia's Largest University Establishes 'Monash Boston Hub' to Accelerate Global Biotech Partnerships and Licensing Business Wire 7:00 AM

-- October 1, 2025 --

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress Globe Newswire 8:00 AM

-- September 22, 2025 --

CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe Globe Newswire 8:30 AM

-- September 9, 2025 --

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025 Globe Newswire 4:00 PM

-- September 2, 2025 --

CRISPR Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 4, 2025 --

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results Globe Newswire 4:15 PM
Market Data Delayed 15 Minutes